CRISPR Genetic Technique Will Be Used to Investigate Hereditary Cancers

10 percent of cancers arise from inherited gene defects. Hereditary cancer syndromes , when identified, help both effective treatment planning for the individual and cancer risk management for the family. In September 2017, Science published a study describing a method for investigating hereditary cancer syndromes in artificial organs using the CRISPR-CAS9 genetic technique.
The Most Common Mutations in Cancer Occur in DNA Repair Genes
As unrepaired damage accumulates, a cell begins proliferating uncontrollably. DNA repair gene mutations may be germline. Germline mutations carry a very high risk of developing cancer for individuals who have them.
Researchers examined the role of inherited DNA repair gene mutations in breast and colon cancer development. For this purpose, stem cells were used to create organoids (organ-like structures). Mutations were induced in specific genes using crispr to investigate their role in cancer development.
According to the Research Results:
- Mutations in the MLH1 and NTHL1 genes were observed to cause colon and breast cancer development.
What Does This Study Mean for Us?
- Organoids have become increasingly important in cancer research. In recent years, some cancer drugs have been tested in organoids rather than experimental animals or humans.
- Inducing a mutation in a specific gene in artificial organs using Crispr can identify which cancer types particular gene mutations may trigger. This may enable effective risk planning and preventive treatments.
Sources
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer.
Science. 2017 Sep 14.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.